Interested in synthetic lethality as a therapeutic strategy? Check out Faye Johnson and colleagues’ work at the #AACR26 Mechanisms of Anticancer Drug Action poster session & read the paper on targeting TRIP13 and Aurora A in Rb-deficient cancer cells. https://t.co/i9r44mq83i https://t.co/4fEf5SDERM